---
$id: https://graph.org.ai/products/commodity/51201545
$type: Product
source: UNSPSC
code: "51201545"
title: "Gusperimus"
class: "51201500"
classTitle: "Immunosuppressants"
family: "51200000"
familyTitle: "Immunomodulating drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Gusperimus

**UNSPSC Code**: 51201545
**Class**: [Immunosuppressants](Immunosuppressants.mdx)
**Family**: [Immunomodulating drugs](../Immunomodulating drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an immunosuppressant with the molecular formula C17H37N7O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier UJ0ZJ76DO9, chemically known as spergualin, 15-deoxy but generally known as gusperimus, which bears US NIH Compound Identifier 55362. European Medicines Agency schedules Gusperimus in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07991MIG. World Health Organization schedules gusperimus in its Anatomical Therapeutic Chemical (ATC) Classification. GUSPERIMUS is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule gusperimus under HS 29252900 and SITC 51482. As of Q4 2014, GUSPERIMUS remains the US FDA Preferred Term for this commodity. SMILES: OC(NC(=O)CCCCCC/N=C(/N)N)C(=O)NCCCCNCCCN.

